Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review.
Cortes Rivera, Mateo, Mastronardi, Claudio, Silva-Aldana, Claudia T et al. · Diagnostics (Basel, Switzerland) · 2019 · DOI
Quick Summary
ME/CFS is a serious, long-lasting illness that affects the brain and causes extreme fatigue and other symptoms, but doctors don't yet know what causes it. The condition is three times more common in women than men, usually starts between ages 20 and 45, and currently has no specific cure. This review summarizes what scientists know about ME/CFS by looking at how it affects the nervous system, immune system, and hormones.
Why It Matters
This review provides clinicians and patients with a framework for understanding ME/CFS as a recognized neurobiological disorder affecting multiple body systems, validating the condition's legitimacy within the medical and scientific community. Understanding the three-system involvement (neuro-immuno-endocrinological) helps direct future research toward more targeted therapeutic approaches and may improve clinical recognition and diagnostic confidence.
Observed Findings
ME/CFS shows a 3:1 female-to-male prevalence ratio
Peak age of disease onset occurs between 20 and 45 years
Clinical features are well-established but diagnosis requires exclusion of other conditions
Three pathophysiological systems are consistently implicated: neurological, immunological, and endocrinological
No specific pharmacological treatments currently exist for ME/CFS
Inferred Conclusions
The complexity of ME/CFS requires understanding the interaction between nervous system, immune system, and hormonal dysfunction rather than single-system models
Current diagnostic approaches depend on ruling out other diseases because specific positive biomarkers for ME/CFS have not been established
Therapeutic development must address the neuro-immuno-endocrinological pattern to effectively improve patient outcomes
Future research should focus on identifying the interconnections between these three biological systems
Remaining Questions
What specific genetic factors predispose individuals to ME/CFS, and how do they interact with environmental triggers?
What This Study Does Not Prove
As a review article, this study does not generate new experimental data or prove causation for any specific mechanism—it synthesizes existing knowledge. It does not establish which factor (neurological, immunological, or endocrinological dysfunction) is primary versus secondary, nor does it demonstrate efficacy of any particular treatment. The diagnosis-by-exclusion approach it describes highlights that we still lack a positive biomarker test.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.